Atlas Trials

Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression

Clinical trial NCT06004115 · RECRUITING

Trial details

NCT number
NCT06004115
Sponsor
Laureate Institute for Brain Research, Inc.
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Depression, AnxietyFearDepressionAnxiety and FearAnxiety DisordersAnxious Depression
Start date
2023-11-08
Primary completion
2027-12-31
Enrollment
165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.